Chase Investment Counsel Corp. »

Stoke Therapeutics shares owned by Chase Investment Counsel Corp.

Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by Chase Investment Counsel Corp. from 13F filings

Historical chart of Chase Investment Counsel Corp. investment in Stoke Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Stoke Therapeutics held by Chase Investment Counsel Corp. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stoke Therapeutics by Chase Investment Counsel Corp.

Quarter filed Position value Share count Share price at filing
2024-03-31 $279k 21k 13.45